SE9402001D0 - Pyridylbisphosphonates for use as a therapeutical agent - Google Patents

Pyridylbisphosphonates for use as a therapeutical agent

Info

Publication number
SE9402001D0
SE9402001D0 SE9402001A SE9402001A SE9402001D0 SE 9402001 D0 SE9402001 D0 SE 9402001D0 SE 9402001 A SE9402001 A SE 9402001A SE 9402001 A SE9402001 A SE 9402001A SE 9402001 D0 SE9402001 D0 SE 9402001D0
Authority
SE
Sweden
Prior art keywords
bisphosphonates
pyridyl
therapeutic agent
bone diseases
pyridinylaminomethylidene
Prior art date
Application number
SE9402001A
Other languages
English (en)
Inventor
Marjaana Heikkilae-Hoikka
Hannu Nikander
Ritva Hannuniemi
Leena Lauren
Terttu Kleimola
Sirpa Liukko-Sipi
Kalervo Vaeaenaenen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Priority to SE9402001A priority Critical patent/SE9402001D0/sv
Publication of SE9402001D0 publication Critical patent/SE9402001D0/sv
Priority to UA97010075A priority patent/UA43918C2/uk
Priority to ES95920122T priority patent/ES2162919T3/es
Priority to KR1019960706991A priority patent/KR100363692B1/ko
Priority to AT95920122T priority patent/ATE208622T1/de
Priority to JP50040096A priority patent/JP3883137B2/ja
Priority to DK95920122T priority patent/DK0762883T3/da
Priority to CN95193416A priority patent/CN1077792C/zh
Priority to CA002192456A priority patent/CA2192456C/en
Priority to PT95920122T priority patent/PT762883E/pt
Priority to EE9600191A priority patent/EE03475B1/xx
Priority to SK1572-96A priority patent/SK282650B6/sk
Priority to RO96-02286A priority patent/RO119433B1/ro
Priority to EP95920122A priority patent/EP0762883B1/en
Priority to RU97100161/14A priority patent/RU2154482C2/ru
Priority to US08/750,355 priority patent/US5866556A/en
Priority to HU9603375A priority patent/HU228618B1/hu
Priority to SI9530523T priority patent/SI0762883T1/xx
Priority to PL95317612A priority patent/PL180705B1/pl
Priority to AU25698/95A priority patent/AU691616B2/en
Priority to PCT/FI1995/000315 priority patent/WO1995033466A1/en
Priority to BR9508185A priority patent/BR9508185A/pt
Priority to DE69523914T priority patent/DE69523914T2/de
Priority to CZ19963561A priority patent/CZ291477B6/cs
Priority to NZ287094A priority patent/NZ287094A/en
Priority to IS4392A priority patent/IS1801B/is
Priority to FI964849A priority patent/FI117053B/sv
Priority to NO19965228A priority patent/NO311069B1/no
Priority to BG101116A priority patent/BG63104B1/bg
Priority to HK98113970A priority patent/HK1012572A1/xx
Priority to US09/219,692 priority patent/US6083938A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE9402001A 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent SE9402001D0 (sv)

Priority Applications (31)

Application Number Priority Date Filing Date Title
SE9402001A SE9402001D0 (sv) 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent
UA97010075A UA43918C2 (uk) 1994-06-09 1995-02-06 Засіб для лікування захворювань кісток, фармацевтична композиція, спосіб лікування захворювань кісток
NZ287094A NZ287094A (en) 1994-06-09 1995-06-02 Pyridinyl-aminomethylidenebiphosphonic acid tetraesters and medicaments thereof
RU97100161/14A RU2154482C2 (ru) 1994-06-09 1995-06-02 Использование пиридилбифосфонатов в качестве терапевтического средства
SI9530523T SI0762883T1 (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent
AT95920122T ATE208622T1 (de) 1994-06-09 1995-06-02 Pyridylbisphosphonate als therapeutische wirkstoffe
JP50040096A JP3883137B2 (ja) 1994-06-09 1995-06-02 ピリジルビスホスホン酸エステルよりなる治療用活性薬剤
DK95920122T DK0762883T3 (da) 1994-06-09 1995-06-02 Pyridylbisphosphonater til anvendelse som terapeutisk middel
CN95193416A CN1077792C (zh) 1994-06-09 1995-06-02 用作治疗剂的吡啶基二膦酸酯
CA002192456A CA2192456C (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent
PT95920122T PT762883E (pt) 1994-06-09 1995-06-02 Piridilbisfosfonatos utilizaveis como agentes terapeuticos
EE9600191A EE03475B1 (et) 1994-06-09 1995-06-02 Püridinüülbisfosfonaatide kasutamine terapeutiliste toimeainetena
SK1572-96A SK282650B6 (sk) 1994-06-09 1995-06-02 Tetraestery kyseliny pyridinyl-aminometylidénbisfosfónovej, farmaceutický prostriedok s ich obsahom a ich použitie
RO96-02286A RO119433B1 (ro) 1994-06-09 1995-06-02 Tetraesteri ai acidului piridinil-aminometilidenbisfosfonic, compoziţie farmaceutică pentru tratamentul afecţiunilor osoase şi utilizarea acestora
EP95920122A EP0762883B1 (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent
ES95920122T ES2162919T3 (es) 1994-06-09 1995-06-02 Piridilbisfosfonatos para uso como agente terapeutico.
US08/750,355 US5866556A (en) 1994-06-09 1995-06-02 Pyridinylbisphosphonates for use as a therapeutical agent
HU9603375A HU228618B1 (en) 1994-06-09 1995-06-02 Medical compositions comprising pyridylbisphosphonate compounds and their use
KR1019960706991A KR100363692B1 (ko) 1994-06-09 1995-06-02 치료제용도의피리딜비스인산염
PL95317612A PL180705B1 (pl) 1994-06-09 1995-06-02 Kompozycja farmaceutyczna do leczenia chorób kosci PL PL PL PL PL PL
AU25698/95A AU691616B2 (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent
PCT/FI1995/000315 WO1995033466A1 (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent
BR9508185A BR9508185A (pt) 1994-06-09 1995-06-02 Composto de tetraésteres de ácido piridinil-aminometilideno- bisfônico composição farmacêutica processo para fabricar uma composição farmacêutica e método para tratar doenças ósseas
DE69523914T DE69523914T2 (de) 1994-06-09 1995-06-02 Pyridylbisphosphonate als therapeutische wirkstoffe
CZ19963561A CZ291477B6 (cs) 1994-06-09 1995-06-02 Deriváty tetraesteru kyseliny pyridylaminomethylidenbisfosfonové, farmaceutický přípravek je obsahující a jejich použití
IS4392A IS1801B (is) 1994-06-09 1996-12-02 Pýridýlbisfosfónöt til notkunar sem efni til lækninga
FI964849A FI117053B (sv) 1994-06-09 1996-12-04 Pyridylbisfosfonater att användas som terapeutiskt medel
NO19965228A NO311069B1 (no) 1994-06-09 1996-12-06 Pyridylbisfosfonater for anvendelse som terapeutisk middel
BG101116A BG63104B1 (bg) 1994-06-09 1997-01-06 Пиридилбисфосфонати и използването им като терапевтични средства
HK98113970A HK1012572A1 (en) 1994-06-09 1998-12-17 Pyridylbishopsphonates for use as a therapeutical agent
US09/219,692 US6083938A (en) 1994-06-09 1998-12-23 Pyridinylbisphosphonates for use as a therapeutical agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402001A SE9402001D0 (sv) 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent

Publications (1)

Publication Number Publication Date
SE9402001D0 true SE9402001D0 (sv) 1994-06-09

Family

ID=20394303

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402001A SE9402001D0 (sv) 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent

Country Status (27)

Country Link
US (2) US5866556A (sv)
EP (1) EP0762883B1 (sv)
JP (1) JP3883137B2 (sv)
KR (1) KR100363692B1 (sv)
CN (1) CN1077792C (sv)
AT (1) ATE208622T1 (sv)
AU (1) AU691616B2 (sv)
BG (1) BG63104B1 (sv)
BR (1) BR9508185A (sv)
CZ (1) CZ291477B6 (sv)
DE (1) DE69523914T2 (sv)
DK (1) DK0762883T3 (sv)
EE (1) EE03475B1 (sv)
ES (1) ES2162919T3 (sv)
HK (1) HK1012572A1 (sv)
HU (1) HU228618B1 (sv)
IS (1) IS1801B (sv)
NO (1) NO311069B1 (sv)
NZ (1) NZ287094A (sv)
PL (1) PL180705B1 (sv)
PT (1) PT762883E (sv)
RO (1) RO119433B1 (sv)
RU (1) RU2154482C2 (sv)
SE (1) SE9402001D0 (sv)
SK (1) SK282650B6 (sv)
UA (1) UA43918C2 (sv)
WO (1) WO1995033466A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2240106T3 (es) * 1999-05-21 2005-10-16 Novartis Ag Uso de acidos bisfosfonicos para el tratamiento de angiogenesis.
US20020103161A1 (en) 1999-12-17 2002-08-01 Manfred Weigele Novel heterocycles
JP2003531111A (ja) 1999-12-17 2003-10-21 アライアッド・ファーマシューティカルズ・インコーポレーテッド プロトンポンプインヒビター
JP2003532632A (ja) * 1999-12-17 2003-11-05 アライアッド・ファーマシューティカルズ・インコーポレーテッド 新規の複素環
DE60126638T2 (de) * 2000-10-27 2007-11-22 Bayer Schering Pharma Ag Bisphosphonsäurederivate zur stärkung von kortikalknochen
EP1482897A2 (en) * 2002-02-19 2004-12-08 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
TW200413381A (en) * 2002-11-04 2004-08-01 Hoffmann La Roche Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
US20050010305A1 (en) * 2003-01-28 2005-01-13 Lee Francis Y. Novel bone graft composite
US20050065171A1 (en) * 2003-06-25 2005-03-24 Shakespeare William C. Substituted purine derivatives
JP2005060303A (ja) * 2003-08-12 2005-03-10 Sutaagen:Kk 不動性骨粗鬆の治療または予防剤
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447256A (en) * 1891-02-24 Apparatus for flashing and exhausting incandescent electric lamps
US4447256A (en) * 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
HU199151B (en) * 1987-03-10 1990-01-29 Yamanouchi Pharma Co Ltd Process for producing bis-phosphonic acid derivatives
KR880011136A (ko) * 1987-03-11 1988-10-26 모리오까 시게오 아졸- 아미노메틸렌 비스포스폰산 유도체

Also Published As

Publication number Publication date
CZ291477B6 (cs) 2003-03-12
HK1012572A1 (en) 1999-08-06
AU691616B2 (en) 1998-05-21
AU2569895A (en) 1996-01-04
CN1077792C (zh) 2002-01-16
EE03475B1 (et) 2001-08-15
HUT75525A (en) 1997-05-28
HU9603375D0 (en) 1997-01-28
JP3883137B2 (ja) 2007-02-21
KR100363692B1 (ko) 2003-02-07
HU228618B1 (en) 2013-04-29
PL180705B1 (pl) 2001-03-30
BR9508185A (pt) 1997-08-12
SK282650B6 (sk) 2002-10-08
PL317612A1 (en) 1997-04-14
EE9600191A (et) 1997-06-16
US6083938A (en) 2000-07-04
NO965228D0 (no) 1996-12-06
IS4392A (is) 1996-12-02
NZ287094A (en) 1998-04-27
CN1149830A (zh) 1997-05-14
DK0762883T3 (da) 2002-03-11
US5866556A (en) 1999-02-02
ES2162919T3 (es) 2002-01-16
PT762883E (pt) 2002-05-31
NO965228L (no) 1996-12-06
NO311069B1 (no) 2001-10-08
SK157296A3 (en) 1997-06-04
RU2154482C2 (ru) 2000-08-20
ATE208622T1 (de) 2001-11-15
EP0762883A1 (en) 1997-03-19
JPH10500977A (ja) 1998-01-27
DE69523914D1 (en) 2001-12-20
BG63104B1 (bg) 2001-04-30
WO1995033466A1 (en) 1995-12-14
KR970703152A (ko) 1997-07-03
DE69523914T2 (de) 2002-06-27
UA43918C2 (uk) 2002-01-15
IS1801B (is) 2002-01-22
BG101116A (en) 1998-03-31
CZ356196A3 (en) 1997-07-16
EP0762883B1 (en) 2001-11-14
RO119433B1 (ro) 2004-11-30

Similar Documents

Publication Publication Date Title
ES2169046T3 (es) Analogo de prostaglandina para el tratamiento de la osteoporosis.
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
SE8704248D0 (sv) Medical use
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
IL104109A0 (en) Pharmaceutical compositions containing aldenorate for treating periodontal diseases
DK0833643T3 (da) Formuleringer af vandfrit mononatriumsalt af alendronat og deres anvendelse til behandling af knoglesygdomme
SE9402001D0 (sv) Pyridylbisphosphonates for use as a therapeutical agent
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
DE69501359T2 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
HK1029937A1 (en) Use of phanquinone for the treatment of alzheimer s disease.
SE8903529D0 (sv) Medical use
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
MX9606180A (es) Piridilbisfosfonatos para utilizarse como un agente terapeutico.
CA2192456A1 (en) Pyridylbisphosphonates for use as a therapeutical agent
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
FR2613621B1 (fr) Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
FR2778104B1 (fr) Utilisation d'un vecteur d'ions fluorure pour la preparation d'un medicament destine a la prevention ou au traitement de maladies associees a helicobacter pylori